Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women

European Journal of Endocrinology

Volumn 157, Issue 3, 2007, Pages 303-310

  Bulló, Mònica ^a   Peeraully, Muhammad R ^b   Trayhurn, Paul ^b   Folch, J ^c   Salas Salvadó, Jordi ^a,d  

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; UPREGULATION; WAIST CIRCUMFERENCE; WEIGHT GAIN;

EID: 35348983385     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-06-0716     Document Type: Article

References (46)

1. Trayhurn P & Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceedings of the Nutrition Society 2001 60 329-339.
2. Rajala MW & Scherer PE. Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003 144 3765-3773.
3. Trayhurn P & Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004 92 347-355.
4. Trayhurn P. Adipose tissue in obesity - an inflammatory issue. Endocrinology 2005 146 1003-1005.
5. Bulló M, García-Lorda P & Salas-Salvadó J. Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. European Journal of Endocrinology 2002 146 325-331.
6. Bulló M, García-Lorda P & Salas-Salvadó J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obesity Research 2003 11 525-531.
7. Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, Scartabelli G, Pardini E, Lopez-Soriano J, Centoni R, Ciccarone AM, Benzi L, Vitti P, Del Prato S, Pinchera A & Maffei M. Serum haptoglobin: a novel marker of adiposity in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 2678-2683.
8. Weyer C, Funahasshi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA. Hypoadiporiectinemia in obesity and type 2 diabetes:close asociation with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
9. Bulló M, Salas Salvadó J & García-Lorda P. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obesity Surgery 2005 15 382-386.
10. Chaldakov GN, Fiore M, Hristova MG & Aloe L. Metabotrophic potential of neurotrophins: implication in obesity and related diseases? Medical Science Monitor 2003 9 HY19-HY21.
11. Hristova M & Aloe L. Metabolic syndrome-neurotrophic hypothesis. Medical Hypotheses 2006 66 545-549.
12. Peeraully MR, Jenkins JR & Trayhurn P. NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. American Journal of Physiology, Endocrinology and Metabolism 2004 287 E331-E339.
13. Wang B, Jenkins JR & Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-α. American Journal of Physiology, Endocrinology and Metabolism 2005 288 E731-E740.
14. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987 237 1154-1162.
15. Barde YA. The nerve growth factor family. Progress in Growth Factor Research 1990 2 237-248.
16. Thoenen H, Bandtlow C & Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Reviews of Physiology, Biochemistry and Pharmacology 1987 109 145-178.
17. Levi-Montalcini R. Effects of mouse tumor transplantation on the nervous system. Annals of the New York Academy of Sciences 1952 55 330-543.
18. Aloe L, Simone MD & Properzi F. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microscopic Research and Technique 1999 45 285-291.
19. Vega JA, Garcia-Suarez O, Hannestad J, Perez-Perez M & Germana A. Neurotrophins and the immune system. Journal of Anatomy 2003 203 1-19.
20. Dicou E, Masson C, Jabbour W & Nerriere V. Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients. Neuroreport 1993 5 321-324.
21. Bonini SE, Lambiase A, Bonini ST, Angelucci F, Magrini L, Manni L & Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. PNAS 1996 93 10955-10960.
22. Azar ST, Major SC & Satieh-Garabedian B. Altered plasma levels of nerve growth factor and transforming growth factor-β2 in type-1 diabetes mellitus. Brain, Behavior, and Immunity 1999 13 361-366.
23. Gadient RA, Cron KC & Otten U. Interleukin-1 and tumor necrosis factor synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neuroscience Letters 1990 117 335-340.
24. Friedman WJ, Larkfors L, Ayer-Lelievre C, Ebendal T, Olson L & Persson H. Regulation of β-nerve growth factor expression by inflammatory mediators in hippocampal cultures. Journal of Neuroscience Research 1990 27 374-382.
25. Bulló M, Peeraully MR & Trayhurn P. Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2 and Delta12-PGJ2. American Journal of Physiology. Endocrinology and Metabolism 2005 289 E62-E67.
26. Chaldakov GN, Stankulov IS, Fiore M, Ghenev PI & Aloe L. Nerve growth factor levels and mast cells distribution in human coronary atherosclerosis. Atherosclerosis 2001 159 57-66.
27. Chaldakov GN, Fiore M, Stankulov IS, Hristova M, Antonelli A, Manni L, Ghenev PI, Angelucci F & Aloe L. NGF, BDNF, Leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Archives of Physiology and Biochemistry 2001 109 357-360.
28. Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, Ghenev PI & Aloe L. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Progress in Brain Research 2004 146 279-289.
29. http://www.eatlas.idf.org/Obesity∠d_type_2_diabetes/.
30. National Cholesterol Education Program, Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication, No. 01-3670 May 2001.
31. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA & Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. American Journal of Clinical Nutrition 1988 47 7-14.
32. Lang UE, Gallinat J, Danker-Hopfe H, Bajbouj M & Hellweg R. Nerve growth factor serum concentrations in healthy human voklunteers: physiological variance and stability. Neuroscience Letters 2003 344 13-16.
33. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H & Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? Journal of Experimental Medicine 1999 189 865-870.
34. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR & Schwartz M. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. Journal of Autoimmunity 2000 15 331-345.
35. Nocker WA & Renz H. Neurotrophins in clinical diagnostics: pathophysiology and laboratory investigation. Clinica Chimica Acta 2005 352 49-74.
36. Despres JP, Lemieux I & Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001 322 716-720.
37. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG & Hauner H. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Hormone and Metabolic Research 1996 28 690-693.
38. Luke AH, Rotimi CN, Cooper RS, Long AE, Forrester TE, Wilks R, Bennett FI, Ogunbiyi O, Compton JA & Bowsher RR. Leptin and body composition of Nigerians, Jamaicans, and US blacks. American Journal of Clinical Nutrition 1998 67 391-396.
39. García-Lorda P, Bulló M, Vila R, del Mar Grasa M, Alemany M & Salas-Salvadó J. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females. Diabetes, Nutrition and Metabolism 2001 14 329-336.
40. Martocchia A, Sigala S, Proietti A, D'Urso R, Spano PF, Missale C & Falaschi P. Sex-related variations in serum nerve growth factor concentration in humans. Neuropeptides 2002 36 391-395.
41. Hardardottir I, Grunfeld C & Feingold KR. Effects of endotoxin and cytokines on lipid metabolism. Current Opinion in Lipidology 1994 5 207-215.
42. Nonogaki K, Moser AH, Shigenaga J, Feingolf KR & Grunfeld C. β-nerve growth factor as a mediator of the acute phase response in vivo. Biochemical and Biophysical Research Communications 1996 219 956-961.
43. Nisoli E, Tonello C, Benarese M, Liberini P & Carruba MO. Expression of nerve growth factor in brown adipose tissue: implications for thermogenesis and obesity. Endocrinology 1996 137 495-503.
44. Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M, Cavallini MC, Cellini E, Di Bella D, Erzegovesi S, Foulon C, Gabrovsek M, Gorwood P, Hebebrand J, Hinney A, Holliday J, Hu X, Karwautz A, Kipman A, Komel R, Nacmias B, Remschmidt H, Ricca V, Sorbi S, Wagner G, Treasure J, Collier DA & Estivill X. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Human Molecular Genetics 2004 13 1205-1212.
45. Ng TB & Wong CM. Epidermal and nerve growth factor manifest antilipolytic and lipogenic activities in isolated rat adipocytes. Comparative Biochemistry and Physiology 1985 81 687-689.
46. Bu G, Sun Y, Schwartz AL & Holtzman DM. Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein. Journal of Biological Chemistry 1998 273 13359-13365.